|
|
| Reporter | guest | Assigned To | | |
|---|
| Priority | normal | Severity | minor | Reproducibility | have not tried |
|---|
| Status | new | Resolution | open | |
|---|
| Platform | EuutdtryEvNEbRvxr | OS | ZEwpxSEfFnihda | |
|---|
|
|
| Summary | 0007500: I like it a lot [url=http://taling.nl/site/tamsulosin-ratiopharm-04-tezr]tamsulosin zentiva wikipedia[/url] "The companies clai |
|---|
| Description | I like it a lot [url=http://taling.nl/site/tamsulosin-ratiopharm-04-tezr]tamsulosin zentiva wikipedia[/url] "The companies claim to have complementarities, bothgeographically and in terms of activities. This might well betrue but there will be significant overlaps in many relevantmarkets," said Brussels-based antitrust lawyer Salomé Cisnal deUgarte of Mayer Brown.
|
|---|
| Steps To Reproduce | I like it a lot [url=http://taling.nl/site/tamsulosin-ratiopharm-04-tezr]tamsulosin zentiva wikipedia[/url] "The companies claim to have complementarities, bothgeographically and in terms of activities. This might well betrue but there will be significant overlaps in many relevantmarkets," said Brussels-based antitrust lawyer Salomé Cisnal deUgarte of Mayer Brown.
|
|---|
| Additional Information | I like it a lot [url=http://taling.nl/site/tamsulosin-ratiopharm-04-tezr]tamsulosin zentiva wikipedia[/url] "The companies claim to have complementarities, bothgeographically and in terms of activities. This might well betrue but there will be significant overlaps in many relevantmarkets," said Brussels-based antitrust lawyer Salomé Cisnal deUgarte of Mayer Brown.
|
|---|
| Tags | eZNlOxYeaXJzKZvtR |
|---|
| Attach Tags | |
|---|